Cover Image
Market Research Report

Human Microbiome

Published by Global Industry Analysts, Inc. Product code 907314
Published Content info 146 Pages
Delivery time: 1-2 business days
Price
Back to Top
Human Microbiome
Published: October 1, 2019 Content info: 146 Pages
Description

Human Microbiome market worldwide is projected to grow by US$542.3 Million, driven by a compounded growth of 14.6%. Acute Diarrhea, one of the segments analyzed and sized in this study, displays the potential to grow at over 15.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$476.7 Million by the year 2025, Acute Diarrhea will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 15.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$20.9 Million to the region's size and clout in the next 5 to 6 years. Over US$26 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Diarrhea will reach a market size of US$36.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 14.3% over the next couple of years and add approximately US$94.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, DowDuPont, Inc.; Enterome SA; Merck & Co., Inc.; Metabiomics Corporation; Microbiome Therapeutics, LLC.; Osel, Inc.; Second Genome; Vedanta Biosciences, Inc.; ViThera Pharmaceuticals, Inc.; Yakult Honsha Co., Ltd.

Table of Contents
Product Code: MCP12453

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Human Microbiome Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Human Microbiome Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Human Microbiome Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
  • TABLE 3: Therapeutics (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 4: Therapeutics (Application) Market Share Shift across Key Geographies: 2019 VS 2025
  • TABLE 5: Diagnostics (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 6: Diagnostics (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 7: Probiotics (Product Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Probiotics (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
  • TABLE 9: Prebiotics (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 10: Prebiotics (Product Type) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 11: Foods (Product Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 12: Foods (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
  • TABLE 13: Medical Foods (Product Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 14: Medical Foods (Product Type) Market Percentage Share Distribution by Region/Country: 2019 VS 2025
  • TABLE 15: Drugs (Product Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 16: Drugs (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
  • TABLE 17: Other Product Types (Product Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 18: Other Product Types (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
  • TABLE 19: Acute Diarrhea (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 20: Acute Diarrhea (Disease Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
  • TABLE 21: Obesity (Disease Indication) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 22: Obesity (Disease Indication) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
  • TABLE 23: Diabetes (Disease Indication) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 24: Diabetes (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
  • TABLE 25: Autoimmune Disorders (Disease Indication) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 26: Autoimmune Disorders (Disease Indication) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 27: Cancer (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 28: Cancer (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
  • TABLE 29: Mental Disorders (Disease Indication) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 30: Mental Disorders (Disease Indication) Market Percentage Share Distribution by Region/Country: 2019 VS 2025
  • TABLE 31: Other Diseases (Disease Indication) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 32: Other Diseases (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Human Microbiome Market Share (in %) by Company: 2019 & 2025
    • TABLE 33: United States Human Microbiome Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
    • TABLE 34: Human Microbiome Market Share Breakdown in the United States by Application: 2019 VS 2025
    • TABLE 35: United States Human Microbiome Market Estimates and Projections in US$ Thousand by Product Type: 2018 to 2025
    • TABLE 36: United States Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025
    • TABLE 37: United States Human Microbiome Market Estimates and Projections in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 38: United States Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025
  • CANADA
    • TABLE 39: Canadian Human Microbiome Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 40: Canadian Human Microbiome Market Share Analysis by Application: 2019 VS 2025
    • TABLE 41: Canadian Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018 to 2025
    • TABLE 42: Human Microbiome Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025
    • TABLE 43: Canadian Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 44: Human Microbiome Market in Canada: Percentage Share Breakdown of Sales by Disease Indication for 2019 and 2025
  • JAPAN
    • TABLE 45: Japanese Demand Estimates and Forecasts for Human Microbiome in US$ Thousand by Application: 2018 to 2025
    • TABLE 46: Human Microbiome Market Share Shift in Japan by Application: 2019 VS 2025
    • TABLE 47: Japanese Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Product Type for the Period 2018-2025
    • TABLE 48: Japanese Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025
    • TABLE 49: Japanese Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 50: Japanese Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025
  • CHINA
    • TABLE 51: Chinese Demand for Human Microbiome in US$ Thousand by Application: 2018 to 2025
    • TABLE 52: Chinese Human Microbiome Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 53: Chinese Human Microbiome Market Growth Prospects in US$ Thousand by Product Type for the Period 2018-2025
    • TABLE 54: Chinese Human Microbiome Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025
    • TABLE 55: Chinese Human Microbiome Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 56: Chinese Human Microbiome Market by Disease Indication: Percentage Breakdown of Sales for 2019 and 2025
  • EUROPE
    • Market Facts & Figures
    • European Human Microbiome Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 57: European Human Microbiome Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 58: European Human Microbiome Market Share Shift by Region/Country: 2019 VS 2025
    • TABLE 59: European Human Microbiome Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 60: European Human Microbiome Market Share Analysis by Application: 2019 VS 2025
    • TABLE 61: European Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018-2025
    • TABLE 62: European Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025
    • TABLE 63: European Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025
    • TABLE 64: European Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025
  • FRANCE
    • TABLE 65: Human Microbiome Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
    • TABLE 66: French Human Microbiome Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 67: Human Microbiome Market in France by Product Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 68: French Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025
    • TABLE 69: Human Microbiome Market in France by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 70: French Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025
  • GERMANY
    • TABLE 71: Human Microbiome Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
    • TABLE 72: Human Microbiome Market Share Distribution in Germany by Application: 2019 VS 2025
    • TABLE 73: Human Microbiome Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product Type for the Period 2018-2025
    • TABLE 74: German Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025
    • TABLE 75: Human Microbiome Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 76: German Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025
  • ITALY
    • TABLE 77: Italian Demand for Human Microbiome in US$ Thousand by Application: 2018 to 2025
    • TABLE 78: Italian Human Microbiome Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 79: Italian Human Microbiome Market Growth Prospects in US$ Thousand by Product Type for the Period 2018-2025
    • TABLE 80: Italian Human Microbiome Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025
    • TABLE 81: Italian Human Microbiome Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 82: Italian Human Microbiome Market by Disease Indication: Percentage Breakdown of Sales for 2019 and 2025
  • UNITED KINGDOM
    • TABLE 83: United Kingdom Demand Estimates and Forecasts for Human Microbiome in US$ Thousand by Application: 2018 to 2025
    • TABLE 84: Human Microbiome Market Share Shift in the United Kingdom by Application: 2019 VS 2025
    • TABLE 85: United Kingdom Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Product Type for the Period 2018-2025
    • TABLE 86: United Kingdom Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025
    • TABLE 87: United Kingdom Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025
    • TABLE 88: United Kingdom Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Human Microbiome Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 90: Rest of Europe Human Microbiome Market Share Analysis by Application: 2019 VS 2025
    • TABLE 91: Rest of Europe Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018-2025
    • TABLE 92: Rest of Europe Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025
    • TABLE 93: Rest of Europe Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025
    • TABLE 94: Rest of Europe Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 95: Human Microbiome Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
    • TABLE 96: Asia-Pacific Human Microbiome Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 97: Human Microbiome Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 98: Asia-Pacific Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025
    • TABLE 99: Human Microbiome Market in Asia-Pacific by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 100: Asia-Pacific Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025
  • REST OF WORLD
    • TABLE 101: Rest of World Human Microbiome Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 102: Rest of World Human Microbiome Market Share Analysis by Application: 2019 VS 2025
    • TABLE 103: Rest of World Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018 to 2025
    • TABLE 104: Human Microbiome Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025
    • TABLE 105: Rest of World Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025
    • TABLE 106: Human Microbiome Market in Rest of World: Percentage Share Breakdown of Sales by Disease Indication for 2019 and 2025

IV. COMPETITION

  • DOWDUPONT
  • ENTEROME SA
  • MERCK & CO.
  • METABIOMICS CORPORATION
  • MICROBIOME THERAPEUTICS
  • OSEL, INC.
  • SECOND GENOME
  • VEDANTA BIOSCIENCES, INC.
  • VITHERA PHARMACEUTICALS
  • YAKULT HONSHA

V. CURATED RESEARCH

Back to Top